Here we shed light on the previously unrecognized molecular mechanism underlying aberrant activation of hypoxia response in VHL-intact renal carcinoma and our data uncovered an alternative pathway through which hypoxia response was activated. This evidence concerns the gene VHL and renal carcinoma.